30.40
price down icon0.91%   -0.38
 
loading
Amrep Corp stock is traded at $30.40, with a volume of 16,524. It is down -0.91% in the last 24 hours and up +3.21% over the past month. Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
See More
Previous Close:
$30.78
Open:
$30.52
24h Volume:
16,524
Relative Volume:
1.15
Market Cap:
$162.25M
Revenue:
$44.53M
Net Income/Loss:
$2.23M
P/E Ratio:
7.619
EPS:
3.99
Net Cash Flow:
$10.87M
1W Performance:
+3.46%
1M Performance:
+3.21%
6M Performance:
+46.99%
1Y Performance:
+87.12%
1-Day Range:
Value
$29.62
$30.83
1-Week Range:
Value
$29.30
$31.13
52-Week Range:
Value
$15.38
$31.26

Amrep Corp Stock (AXR) Company Profile

Name
Name
Amrep Corp
Name
Phone
610-487-0905
Name
Address
850 WEST CHESTER PIKE, HAVERTOWN, PA
Name
Employee
28
Name
Twitter
Name
Next Earnings Date
2024-09-11
Name
Latest SEC Filings
Name
AXR's Discussions on Twitter

Amrep Corp Stock (AXR) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-14-07 Upgrade Matrix Research Hold → Buy
Jan-17-07 Downgrade Matrix Research Buy → Hold

Amrep Corp Stock (AXR) Latest News

pulisher
Oct 29, 2024

AMREP Co. (NYSE:AXR) Short Interest Up 16.4% in October - Defense World

Oct 29, 2024
pulisher
Oct 25, 2024

AXR Stock Surges Amid Real Estate Sector Movements - GuruFocus.com

Oct 25, 2024
pulisher
Oct 25, 2024

AMREP (NYSE:AXR) Stock Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

The Zacks Analyst Blog Highlights SAP, Goldman Sachs, Lockheed Martin, AMREP and Nova LifeStyle - Yahoo Finance

Oct 24, 2024
pulisher
Oct 20, 2024

Is AMREP Corporation's (NYSE:AXR) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance

Oct 20, 2024
pulisher
Oct 18, 2024

AXR Stock Surges 6.20% Amid Positive Financial Performance - GuruFocus.com

Oct 18, 2024
pulisher
Oct 17, 2024

Short Interest in AMREP Co. (NYSE:AXR) Declines By 9.7% - MarketBeat

Oct 17, 2024
pulisher
Oct 06, 2024

AMREP Co. (NYSE:AXR) Major Shareholder Purchases $53,910.00 in Stock - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

Amrep corp insider buys $53.9k in company stock - Investing.com India

Oct 05, 2024
pulisher
Oct 04, 2024

Amrep corp insider buys $53.9k in company stock By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 02, 2024

AMREP Corporation (AXR): A Bull Case Theory - MSN

Oct 02, 2024
pulisher
Sep 28, 2024

AMREP Co. (NYSE:AXR) Major Shareholder James H. Dahl Buys 2,000 Shares - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Amrep corp insider buys shares worth nearly $60k By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 27, 2024

Amrep corp insider buys shares worth nearly $60k - Investing.com India

Sep 27, 2024
pulisher
Sep 25, 2024

Amgen stock slides 5% as analysts weigh in on drug study results (update) - Seeking Alpha

Sep 25, 2024
pulisher
Sep 25, 2024

Amgen’s stock falls 4% as analysts say drug updates lag competitors - MarketWatch

Sep 25, 2024
pulisher
Sep 25, 2024

Amgen Stock Falls on Disappointing Drug Data - The Wall Street Journal

Sep 25, 2024
pulisher
Sep 25, 2024

AMREP Corp Stock Soars to 52-Week High of $31.19 Amidst Strong Growth - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Amgen falls after reporting mixed data on two drugs - XM

Sep 25, 2024
pulisher
Sep 25, 2024

Check out these key findings about Amylyx Pharmaceuticals Inc (AMLX) - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

A-Mark Precious Metals, Inc. (NASDAQ:AMRK) Announces Quarterly Dividend of $0.20 - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Analyzing Ratios: Amylyx Pharmaceuticals Inc (AMLX)’s Financial Story Unveiled - The Dwinnex

Sep 25, 2024
pulisher
Sep 25, 2024

Amarin Corp ADR (AMRN) stock analysis: A comprehensive overview - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

1,881 Shares in Alpha Metallurgical Resources, Inc. (NYSE:AMR) Acquired by XTX Topco Ltd - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Epoch Investment Partners Inc. Sells 1,213,043 Shares of Amcor plc (NYSE:AMCR) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

XTX Topco Ltd Takes $453,000 Position in Ameresco, Inc. (NYSE:AMRC) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

American Century Companies Inc. Boosts Stake in Ameresco, Inc. (NYSE:AMRC) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

State of New Jersey Common Pension Fund D Decreases Position in Alpha Metallurgical Resources, Inc. (NYSE:AMR) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

A-Mark Precious Metals, Inc. (NASDAQ:AMRK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

A-Mark Precious Metals (NASDAQ:AMRK) Rating Increased to Hold at StockNews.com - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Amgen stock slips 3% following Phase 3 data for rocatinlimab, Uplizna (NASDAQ:AMGN) - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

Amrep Corp insider buys $92,250 in company stock By Investing.com - Investing.com South Africa

Sep 24, 2024
pulisher
Sep 24, 2024

Amrep Corp insider buys $92,250 in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

A-Mark Precious Metals director sells over $2.6m in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Ratio Analysis: Unpacking America Movil S.A.B.DE C.V. ADR (AMX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Alpha Metallurgical Resources (NYSE:AMR) Shares Up 8.1% - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Insider Move: GREGORY ROBERTS Exercises Options, Realizing $493K At A-Mark Precious Metals - Benzinga

Sep 24, 2024
pulisher
Sep 24, 2024

A year in review: Amylyx Pharmaceuticals Inc (AMLX)’s performance in the last year - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Amgen gets early win in Regeneron lawsuit over Eylea biosimilar - Reuters

Sep 24, 2024
pulisher
Sep 24, 2024

Intech Investment Management LLC Purchases 124,547 Shares of Amcor plc (NYSE:AMCR) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

AE Wealth Management LLC Buys 8,763 Shares of Amcor plc (NYSE:AMCR) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Hsbc Holdings PLC Sells 226,786 Shares of Amcor plc (NYSE:AMCR) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea - Investor's Business Daily

Sep 23, 2024
pulisher
Sep 23, 2024

A-Mark Precious Metals, Inc. (NASDAQ:AMRK) CEO Gregory N. Roberts Sells 4,320 Shares - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

It is Poised to be a Bull Market for Ameris Bancorp (ABCB) - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Alpha Metallurgical Resources Inc (AMR) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

A Guide To The Risks Of Investing In Amylyx Pharmaceuticals Inc (AMLX) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Frank Rimerman Advisors LLC Makes New Investment in Amcor plc (NYSE:AMCR) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

The growth track for Ameresco Inc. (AMRC) has changed recently - SETE News

Sep 23, 2024
pulisher
Sep 22, 2024

ProShare Advisors LLC Boosts Stock Position in Amcor plc (NYSE:AMCR) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Ameresco, Inc. (NYSE:AMRC) Shares Sold by DekaBank Deutsche Girozentrale - Defense World

Sep 22, 2024

Amrep Corp Stock (AXR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
real_estate_development OZ
$66.83
price up icon 0.12%
real_estate_development FPH
$4.09
price up icon 0.49%
real_estate_development LRE
$2.0601
price up icon 7.37%
$11.65
price down icon 1.11%
$9.33
price up icon 1.08%
Cap:     |  Volume (24h):